Pregled bibliografske jedinice broj: 596596
Adjuvant cancer biotherapy by Visum album extract Isorel: Overview of evidence based medicine findings
Adjuvant cancer biotherapy by Visum album extract Isorel: Overview of evidence based medicine findings // Collegium antropologicum, 39 (2015), 3; 701-708 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 596596 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Adjuvant cancer biotherapy by Visum album extract Isorel: Overview of evidence based medicine findings
Autori
Borović Šunjić, Suzana ; Čipak Gašparović, Ana ; Vuković, Tea ; Weiss, Thomas ; Susman Weiss, Elisabeth ; Soldo, Ivo ; Đaković, Nikola ; Žarković, Tomislav ; Žarković, Neven
Izvornik
Collegium antropologicum (0350-6134) 39
(2015), 3;
701-708
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Viscum album ; cancer ; biotherapy ; mistletoe ; lectins ; evidence based medicine
Sažetak
Within the integrative medicine one of the most frequently used adjuvant cancer biotherapies is based on aqueous mistletoe (Viscum album) extracts. Tumor growth inhibition, stimulation of host immune response and improvement of the quality of life are the positive effects of mistletoe therapy described in several preclinical and clinical studies. However, cumulative results of the evidence based medicine findings on such treatments are rarely given. Therefore, this paper evaluates the evidence based findings describing effects of the Viscum album extract Isorel in cancer therapy with respect to the type of therapy, stage and type of illness. This study presents cumulated data for 74 patients with different types and stages of cancer treated by Viscum album extract as adjuvant treatment to different conventional therapies, mostly combined surgery and radiotherapy. The biotherapy effectiveness was evaluated according to the outcome as 1) no major therapeutic improvement (15% of patients), 2) prevention of tumor recurrence (47% of patients) and 3) regression of cancer (38% of patients). Notably, there was no obvious health worsening during the follow up period at all. Thus, the results obtained for conventional anticancer therapies combined with adjuvant biotherapy based on Viscum album extract seem to be benefi cial for the majority of cancer patients (85%) without serious side effects.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-098-0982464-2519 - Lipidi, slobodni radikali i njihovi glasnici u integrativnoj onkologiji (Žarković, Neven, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Klinička bolnica "Sveti Duh",
KBC "Sestre Milosrdnice"
Profili:
Ivo Soldo
(autor)
Nikola Đaković
(autor)
Ana Čipak Gašparović
(autor)
Suzana Borović Šunjić
(autor)
Neven Žarković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE